Medicare Enrolled
Dr. Shahbuddin Mukardamwala, MD
Neurology · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mukardamwala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mukardamwala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mukardamwala
Dr. Shahbuddin Mukardamwala is a neurology specialist in Houston, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mukardamwala performed 1,927 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mukardamwala received a total of $12,083 from 70 pharmaceutical and/or device companies across 668 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mukardamwala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 20% volume in TX
$12,083 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,927
Medicare services
Top 20% in TX for neurology
Not available
Unique patients (not deduplicated)
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
497 | $95 | $210 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
456 | $64 | $147 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
349 | $96 | $267 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
232 | $103 | $278 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
120 | $135 | $376 |
| New patient office visit, complex (60-74 min) | 108 | $170 | $460 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
86 | $129 | $948 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
46 | $72 | $189 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
20 | $79 | $213 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
13 | $108 | $290 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,083
Total received (2018-2024)
Avg $1,726/year across 7 years
Top 24% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
668
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,504
2023
$2,136
2022
$2,345
2021
$1,996
2020
$1,578
2019
$984
2018
$540
Payments by company (2024)
UCB, Inc.
$237
Novartis Pharmaceuticals Corporation
$231
ABBVIE INC.
$223
Otsuka America Pharmaceutical, Inc.
$215
ARGENX US, INC.
$167
Alexion Pharmaceuticals, Inc.
$144
Eisai Inc.
$125
Neurocrine Biosciences, Inc.
$118
Mallinckrodt Hospital Products Inc.
$109
SK Life Science, Inc.
$102
Aucta Pharmaceuticals, Inc.
$85
Genentech USA, Inc.
$81
JAZZ PHARMACEUTICALS INC.
$79
Lundbeck LLC
$62
Takeda Pharmaceuticals U.S.A., Inc.
$57
Grifols USA, LLC
$55
Amneal Pharmaceuticals LLC
$52
Biogen, Inc.
$46
PFIZER INC.
$42
ACADIA Pharmaceuticals Inc
$41
Medtronic, Inc.
$40
Teva Pharmaceuticals USA, Inc.
$38
Celgene Corporation
$23
Lilly USA, LLC
$22
EMD Serono, Inc.
$21
LivaNova USA, Inc.
$19
Kyowa Kirin, Inc.
$19
TG Therapeutics, Inc.
$18
Sumitomo Pharma America, Inc.
$18
InSightec,Inc
$16
Top 3 companies account for 27.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,126
UCB, Inc.
$904
ABBVIE INC.
$780
Neurocrine Biosciences, Inc.
$555
Grifols USA, LLC
$537
Biogen, Inc.
$516
SK Life Science, Inc.
$494
EMD Serono, Inc.
$493
ARGENX US, INC.
$487
Allergan, Inc.
$463
Alexion Pharmaceuticals, Inc.
$450
Otsuka America Pharmaceutical, Inc.
$445
Teva Pharmaceuticals USA, Inc.
$364
Lundbeck LLC
$310
CSL Behring
$205
Eisai Inc.
$204
ACADIA Pharmaceuticals Inc
$201
JAZZ PHARMACEUTICALS INC.
$190
Lilly USA, LLC
$189
Supernus Pharmaceuticals, Inc.
$168
Amgen Inc.
$166
PFIZER INC.
$164
Takeda Pharmaceuticals U.S.A., Inc.
$162
AbbVie Inc.
$159
Avion Pharmaceuticals
$146
Amneal Pharmaceuticals LLC
$135
Biohaven Pharmaceuticals, Inc.
$111
Mallinckrodt Hospital Products Inc.
$109
CATALYST PHARMACEUTICALS, INC.
$100
AQUESTIVE THERAPEUTICS, INC.
$99
Sunovion Pharmaceuticals Inc.
$89
LivaNova USA, Inc.
$88
Sumitomo Pharma America, Inc.
$86
Aucta Pharmaceuticals, Inc.
$85
Allergan Inc.
$82
Genentech USA, Inc.
$81
Janssen Pharmaceuticals, Inc
$77
Acorda Therapeutics, Inc
$68
Medtronic, Inc.
$67
GE HealthCare
$65
Kyowa Kirin, Inc.
$60
Banner Life Sciences, LLC
$59
Vertical Pharmaceuticals, LLC
$57
Biohaven Pharmaceutical Holding Company Ltd.
$52
Corium, LLC
$49
Avanir Pharmaceuticals, Inc.
$46
Bausch Health US, LLC
$44
Celgene Corporation
$38
Upsher-Smith Laboratories LLC
$35
Medtronic USA, Inc.
$34
BANNER LIFE SCIENCES, LLC
$33
EISAI INC.
$29
TG THERAPEUTICS, INC.
$27
Adamas Pharmaceuticals, Inc.
$25
BOSTON SCIENTIFIC CORPORATION
$24
Alnylam Pharmaceuticals Inc.
$21
Mitsubishi Tanabe Pharma America, Inc.
$20
Assertio Therapeutics, Inc.
$19
GE HEALTHCARE
$19
TG Therapeutics, Inc.
$18
Promius Pharma LLC
$18
Aprecia Pharmaceuticals, LLC
$17
Arbor Pharmaceuticals, Inc.
$17
MDD US Operations, LLC
$16
InSightec,Inc
$16
UPSHER-SMITH LABORATORIES LLC
$15
Xeris Pharmaceuticals, Inc.
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
AstraZeneca Pharmaceuticals LP
$13
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 23.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ACTIVA PC · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · APTIOM · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CAMBIA · DIVIGEL · Dhivy · EMGALITY · EPIDIOLEX · Eprontia · Exablate · FIRDAPSE · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · LYRICA · Leqembi · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PERCEPT PC BRAINSENSE · PLEGRIDY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Repatha · Rystiggo · SOLIRIS · SPINRAZA · SYMPAZAN · Soliris · Spritam · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WATCHMAN · XCOPRI · ZEPOSIA · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
346
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE SOUTHEAST
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mukardamwala is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mukardamwala experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Mukardamwala performed 497 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mukardamwala receive payments from pharmaceutical companies?
Yes. Dr. Mukardamwala received a total of $12,083 from 70 companies across 668 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mukardamwala's costs compare to other neurologists in Houston?
Dr. Mukardamwala's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mukardamwala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Houston
Browse neurologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology